ResMed (RMD) Stock Chart - Revenue & Earnings | Quarter Chart

📊 Income Statement

Revenue by Product

Sleep And Respiratory
0250M500M750M1B1B2B2B2BQ3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Revenue by Geography

GlobalSleep And RespiratoryUs Canada And Latin America
0375M750M1B2B2B2B3B3BQ3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Revenue, Gross Profit, Operating and Net Income

RevenueGross ProfitOperating IncomeNet Income
0500M1B2B2B2B3B4B4BQ3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Margin (%)

Gross MarginOperating MarginNet Income Margin
0255075100125150175200Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Operating Expenses

Research And Development ExpensesSelling General And Administrative ExpensesOther Expenses
062M125M188M250M312M375M438M500MQ3 2025Q4 2025Q1 2026Q2 2026Q3 2026

EBITDA

EBITDA
088M175M262M350M438M525M612M700MQ3 2025Q4 2025Q1 2026Q2 2026Q3 2026

EPS

EPSEPS Diluted
012344567Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Revenue Variation (%)

Revenue Variation
-2-10234678Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Income Variation (%)

Gross Profit VariationOperating Income VariationNet Income Variation
0510152025303540Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Revenue YoY Variation (%)

Revenue YoY Variation
02581012151820Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Income YoY Variation (%)

Gross Profit YoY VariationOperating Income YoY VariationNet Income YoY Variation
01020304050607080Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Price-to-Earning Ratio

P/E Ratio
0510152025303540Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Income Breakdown

Rule Of 40 (EBITDA)Rule Of 40 (FCF)
0255075100125150175200Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Per Share Metrics

Operating IncomeInterest IncomeTotal Other Income Expenses NetNet Income
0250M500M750M1B1B2B2B2BQ3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Expense Ratios

Revenue Per ShareNet Income Per ShareOperating Cash Flow Per Share
02581012151820Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026
💰 Cash Flow Statement

Operating Cash Flow

Research And Ddevelopement To RevenueCapex To RevenueStock Based Compensation To Revenue
000001111Q3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Free Cash Flow

Operating Cash FlowCapital ExpenditureFree Cash Flow
0250M500M750M1B1B2B2B2BQ3 2025Q4 2025Q1 2026Q2 2026Q3 2026

Cash Flow to Debt Ratio

Cash At End Of Period
0250M500M750M1B1B2B2B2BQ3 2025Q4 2025Q1 2026Q2 2026Q3 2026
🏦 Balance Sheet
📈 Key Metrics